Table 1.
Descriptor | Posttraumatic Stress Disorder Group (N=20) | Healthy Control Group (N=20) | PTSD vs HC | ||
---|---|---|---|---|---|
p,effect size7 | |||||
Female / Male | 18 F / 2 M | 90 / 10 | 18 F/2 M | 90/ 10 | equal |
Race: White | 10 | 50 | 15 | 75 | Chi2 =2.67, p=.19 |
Current Psychotropic Meds | None | None | None | None | N/A |
Comorbid Diagnoses @ BL | |||||
p,effect size7 | |||||
Age at Pre-Treatment (years) | 15.3 (1.9) | 10.4–17.7 | 14.5 (2) | 11.2–17.5 | p=.18, e.s.=.05 |
Estimate of IQ1 | 110 (9.6) | 93–126 | 113 (11) | 86–130 | p=.39, e.s.=.02 |
PTSD3 at Baseline | 39.1 (10.6) | 24–58 | N/A | N/A | N/A |
PTSD3 at End of Study | 22.9 (9.5) | 5–41 | N/A | N/A | N/A |
PTSD3BL vs EOS | PTSD group: F (1,19)= 37; p=.0001, e.s.=.94 | ||||
Dissociative4 at Baseline | 2.8 (1.7) | 0.1–5.2 | 0.6 (0.7) | 0–3.3 | P=.0001;e.s.=.71 |
Dissociative4 at End of Study | 1.8 (1.3) | 0.3–5.6 | 0.5 (0.5) | 0–1.8 | P=.0001,e.s.=.64 |
Dissociative4 BL vs EOS | PTSD group: F (1,19)= 18.3, p=.0001, e.s.=.49; HC group: F < 1, p=.53, e.s.=.022 | ||||
Depression5 at Baseline | 23.6 (9.0) | 6–38 | 3.5 (3.6) | 0–13 | P=.0001; e.s.=.86 |
Depression5 at End of Study | 13.7 (8.9) | 0–31 | 3.4 (3.0) | 0–12 | P=.0001, e.s.=.70 |
Depression5 BL vs EOS | PTSD group: F (1,19)= 20.1, p=.0001, e.s.=.51; HC group: F < 1, p=.87, e.s.=.001 | ||||
Externalizing6at Baseline | 54.8 (9.4) | 39–69 | 39.2 (7.4) | 32–54 | P=.0001, e.s.=.48 |
Externalizing6 at End of Study | 50.9 (7.4) | 39–63 | 38.9 (6.7) | 32–52 | P=.0001, e.s.=.43 |
Internalizing6 at Baseline | 64.4 (8.1) | 48–78 | 42.1 (9.3) | 31–61 | P=.0001, e.s.=.63 |
Internalizing6 at End of Study | 55.4 (10.0) | 31–73 | 45.6 (7.6) | 31–59 | P=.001, e.s.=.24 |
IQ: Wechsler Abbreviated Scale of Intelligence (WASI);
Anorexia Nervosa, Oppositional Defiant Disorder;
UCLA PTSD Reaction Index for DSM-IV;
A-DES (Adolescent Dissociative Experiences Scale);
CDI (Children’s Depression Inventory instrument);
Child Behavior Checklist (CBCL);
partial eta squared